State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$3.42B |
| 2 |
Cigna
CI
|
+$1.25B |
| 3 |
CVS Health
CVS
|
+$1.25B |
| 4 |
Marathon Petroleum
MPC
|
+$805M |
| 5 |
Diamondback Energy
FANG
|
+$589M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$3.86B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.31B |
| 3 |
PX
Praxair Inc
PX
|
+$2.1B |
| 4 |
Apple
AAPL
|
+$1.38B |
| 5 |
ANDV
Andeavor
ANDV
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.79% |
| 2 | Technology | 15.42% |
| 3 | Healthcare | 14.78% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTIC
3301
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $677K | ﹤0.01% |
922,844
+66,326
| +8% | +$109K |
|
3302
Verrica Pharmaceuticals
VRCA
$90.2M
| $672K | ﹤0.01% |
8,244
+3,284
| +66% | +$399K |
|
3303
Bilibili
BILI
$8.05B
| $663K | ﹤0.01% |
+45,418
| New | +$636K |
|
3304
Mustang Bio
MBIO
$4.37M
| $661K | ﹤0.01% |
300
-24
| -7% | -$73K |
|
|
SMAR
3305
DELISTED
Smartsheet Inc.
SMAR
| $658K | ﹤0.01% |
26,472
+17,772
| +204% | +$442K |
|
3306
Empire State Realty Series ES
ESBA
$1.34B
| $654K | ﹤0.01% |
+46,201
| New | +$720K |
|
3307
Kodiak Sciences
KOD
$2.49B
| $651K | ﹤0.01% |
+91,677
| New | +$812K |
|
|
SLAI
3308
DELISTED
SOLAI Ltd ADS
SLAI
| $648K | ﹤0.01% |
1,221
+50
| +4% | +$28.3K |
|
|
PFIE
3309
DELISTED
Profire Energy, Inc
PFIE
| $647K | ﹤0.01% |
445,864
+45,375
| +11% | +$106K |
|
3310
RELX
RELX
$64.2B
| $645K | ﹤0.01% |
31,455
-4,057
| -11% | -$82.3K |
|
|
SURF
3311
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $644K | ﹤0.01% |
151,847
+25,897
| +21% | +$200K |
|
3312
Ramaco Resources Class A
METC
$581M
| $643K | ﹤0.01% |
134,343
+4,540
| +3% | +$27.8K |
|
3313
China Yuchai International
CYD
$1.74B
| $642K | ﹤0.01% |
51,610
-10,223
| -17% | -$147K |
|
|
PIR
3314
DELISTED
Pier 1 Imports, Inc.
PIR
| $633K | ﹤0.01% |
103,422
+522
| +0.5% | +$14.3K |
|
|
LOGC
3315
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $625K | ﹤0.01% |
+60,118
| New | +$726K |
|
3316
Transcontinental Realty Investors
TCI
$357M
| $620K | ﹤0.01% |
21,892
+437
| +2% | +$14.2K |
|
|
QIWI
3317
DELISTED
QIWI PLC
QIWI
| $612K | ﹤0.01% |
43,286
+2,582
| +6% | +$34.8K |
|
|
NYMX
3318
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $611K | ﹤0.01% |
466,747
-13,616
| -3% | -$24.9K |
|
3319
Valhi
VHI
$380M
| $603K | ﹤0.01% |
26,051
-2,044
| -7% | -$51.3K |
|
3320
Babcock & Wilcox
BW
$1.42B
| $602K | ﹤0.01% |
154,206
-4,392
| -3% | -$39.1K |
|
|
SN
3321
DELISTED
Sanchez Energy Corporation
SN
| $601K | ﹤0.01% |
2,227,233
+647,343
| +41% | +$829K |
|
|
HNGR
3322
DELISTED
Hanger Inc.
HNGR
| $600K | ﹤0.01% |
+31,636
| New | +$611K |
|
|
MTEM
3323
DELISTED
Molecular Templates, Inc.
MTEM
| $593K | ﹤0.01% |
9,790
+387
| +4% | +$27K |
|
3324
FuelCell Energy
FCEL
$1.8B
| $589K | ﹤0.01% |
2,970
-396
| -12% | -$113K |
|
3325
YPF
YPF
$20B
| $587K | ﹤0.01% |
+43,836
| New | +$644K |
|
Similar funds
State Street's Q4 2018 Portfolio in Review
As of Q4 2018, State Street held 3,872 positions worth $1.1T, down 16% from $1.3T the previous quarter. Its ten largest holdings account for 17% of the portfolio.
State Street's Q4 2018 filing shows 102 new, 1,442 increased, 2,108 reduced and 110 closed positions. Its largest new stake was Linde: 21,625,224 shares worth $3.37B. The largest sale was Aetna Inc, an estimated $3.86B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- State Street's largest Q4 2018 buy was Linde: 21,625,224 shares worth $3.37B.
- State Street added most to Cigna in Q4 2018, an estimated $1.25B increase.
- State Street's biggest Q4 2018 reduction was Apple, cutting an estimated $1.38B.
- State Street fully exited Aetna Inc in Q4 2018, selling an estimated $3.86B.
- State Street's ten largest holdings make up 17% of its $1.1T portfolio in Q4 2018.
- State Street opened 102 new positions and closed 110 in Q4 2018.
- State Street's portfolio value fell 16% quarter-over-quarter to $1.1T.
Based on State Street's 13F filing for Q4 2018, filed 12 Feb 2019.